Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 139,163 | 134,224 | 121,984 | 114,802 | 117,549 |
| Cost of Goods | 50,348 | 58,598 | 54,757 | 53,705 | 54,216 |
| Gross Profit | 88,815 | 75,626 | 67,227 | 61,097 | 63,333 |
| Operating Expenses | 26,411 | 25,212 | 25,186 | 26,921 | 25,226 |
| Operating Income | 62,752 | 51,012 | 42,798 | 34,881 | 38,323 |
| Interest Expense | 1,626 | 1,675 | 1,834 | 1,975 | 2,879 |
| Other Income | 468 | -1,822 | -867 | 544 | -731 |
| Pre-tax Income | 61,594 | 47,515 | 40,097 | 33,450 | 34,713 |
| Income Tax | 12,215 | 11,087 | 5,878 | 6,546 | -77,183 |
| Net Income Continuous | 49,379 | 36,428 | 34,219 | 26,904 | 111,896 |
| Net Income | $49,379 | $36,428 | $34,219 | $26,904 | $111,896 |
| EPS Basic Total Ops | 0.22 | 0.15 | 0.14 | 0.11 | 0.48 |
| EPS Basic Continuous Ops | 0.21 | 0.15 | 0.14 | 0.11 | 0.48 |
| EPS Diluted Total Ops | 0.20 | 0.15 | 0.14 | 0.11 | 0.45 |
| EPS Diluted Continuous Ops | 0.20 | 0.15 | 0.14 | 0.11 | 0.46 |
| EPS Diluted Before Non-Recurring Items | 0.20 | 0.16 | 0.15 | 0.14 | 0.14 |
| EBITDA(a) | $64,959 | $53,169 | $44,981 | $37,004 | $40,450 |